Clinical Trials Browser

cyclopia sequence, Emergence Delirium, Postoperative Cognitive Complications, Carcinoma, Renal Cell, Colonic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

NCT03623425 2018-08-09

TEPGALCHOL

Phase 3 Unknown

46 enrolled

Genitourinary

Prostatic Neoplasms

NCT03406169 2018-01-23

Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy

Phase 3 Unknown

180 enrolled

Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT02934685 2016-11-18

IG-VMAT for Localized Prostate Cancer

Phase 3 Unknown

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT02367404 2016-09-13

Prospective RCT on Post Prostatectomy Urine Leak

Phase 3 Unknown

240 enrolled

Genitourinary

Prostatic Neoplasms, Urinary Incontinence

NCT00003734 2016-07-21

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3 Unknown

276 enrolled

Genitourinary

Prostatic Neoplasms

NCT01978873 2016-05-04

SensiCab

Phase 3 Unknown

400 enrolled

Genitourinary

Prostatic Neoplasms

NCT02668718 2016-02-02

Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer

Phase 3 Unknown

250 enrolled

Genitourinary

Prostatic Neoplasms

NCT00175396 2014-03-17

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Phase 3 Unknown

400 enrolled

Genitourinary

Prostatic Neoplasms

NCT00363285 2013-08-26

Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

Phase 3 Unknown

900 enrolled

Genitourinary

Prostatic Neoplasms

NCT00376792 2013-08-26

Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Phase 3 Unknown

396 enrolled

Genitourinary

Prostatic Neoplasms

NCT00796458 2013-08-12

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

Phase 3 Unknown

200 enrolled

Genitourinary

Pain, Prostatic Neoplasms

NCT00110162 2013-08-07

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

Phase 3 Unknown

2,000 enrolled

Genitourinary

Prostatic Neoplasms

NCT01540656 2013-05-24

Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy Incontinence

Phase 3 Unknown

39 enrolled

Genitourinary

Prostatic Neoplasms, Urinary Incontinence, Urinary Incontinence, Stress

NCT01839994 2013-04-25

Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer

Phase 3 Unknown

350 enrolled

Genitourinary

Prostatic Neoplasms

NCT01398657 2012-11-14

Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer

Phase 3 Unknown

182 enrolled

Genitourinary

Prostatic Neoplasms

NCT00502723 2012-07-30

PROPENLAP

Phase 3 Unknown

1,440 enrolled

Genitourinary

Prostatic Neoplasms

NCT01087268 2011-07-15

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Phase 3 Unknown

75 enrolled

GastrointestinalGenitourinaryGynecologicSarcoma

Testicular Germ Cell Tumor, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Radiation Injuries, Rectal Neoplasms, Sarcoma, Testicular Neoplasms, Vaginal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT00957606 2011-04-13

Osteoporosis

Phase 3 Unknown

100 enrolled

Genitourinary

Osteoporosis, Prostatic Neoplasms

NCT00486499 2007-06-14

I-125 Versus Pd-103 for Medium Risk Prostate Cancer

Phase 3 Unknown

660 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00201630 2005-09-20

Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy

Phase 3 Unknown

150 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

Clinical Trials

MAST

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

Transamin

ESTO2

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer

A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation

PATCH

RaRe

MAPOCD

TEPGALCHOL

Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy

IG-VMAT for Localized Prostate Cancer

Prospective RCT on Post Prostatectomy Urine Leak

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

SensiCab

Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy Incontinence

Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer

Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer

PROPENLAP

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Osteoporosis

I-125 Versus Pd-103 for Medium Risk Prostate Cancer

Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy